世界最新医学信息文摘(连续型电子期刊)
世界最新醫學信息文摘(連續型電子期刊)
세계최신의학신식문적(련속형전자기간)
World Latest Medicine Information
2015年
20期
6-6,8
,共2页
高血压%冠心病%吲达帕胺%氨氯地平%临床疗效
高血壓%冠心病%吲達帕胺%氨氯地平%臨床療效
고혈압%관심병%신체파알%안록지평%림상료효
Hypertension%Coronary heart disease (CHD)%Indapamide%Amlodipine%Clinical effect
目的:分析高血压合并冠心病患者行吲达帕胺联合氨氯地平治疗的临床疗效。方法收集我院2012年5月至2014年7月期间诊治的68例高血压合并冠心病患者作为研究对象,随机分为试验组(34例)与对照组(34例),对照组患者给予硝苯地平控释片治疗,试验组采用吲达帕胺联合氨氯地平治疗,观察患者的治疗效果和不良反应。结果试验结果表明,试验组患者的整体疗效显著高于对照组(P<0.05)。两组患者在不良反应方面比较无明显差异(P>0.05)。结论高血压合并冠心病患者行吲达帕胺联合氨氯地平治疗具有良好的临床疗效。
目的:分析高血壓閤併冠心病患者行吲達帕胺聯閤氨氯地平治療的臨床療效。方法收集我院2012年5月至2014年7月期間診治的68例高血壓閤併冠心病患者作為研究對象,隨機分為試驗組(34例)與對照組(34例),對照組患者給予硝苯地平控釋片治療,試驗組採用吲達帕胺聯閤氨氯地平治療,觀察患者的治療效果和不良反應。結果試驗結果錶明,試驗組患者的整體療效顯著高于對照組(P<0.05)。兩組患者在不良反應方麵比較無明顯差異(P>0.05)。結論高血壓閤併冠心病患者行吲達帕胺聯閤氨氯地平治療具有良好的臨床療效。
목적:분석고혈압합병관심병환자행신체파알연합안록지평치료적림상료효。방법수집아원2012년5월지2014년7월기간진치적68례고혈압합병관심병환자작위연구대상,수궤분위시험조(34례)여대조조(34례),대조조환자급여초분지평공석편치료,시험조채용신체파알연합안록지평치료,관찰환자적치료효과화불량반응。결과시험결과표명,시험조환자적정체료효현저고우대조조(P<0.05)。량조환자재불량반응방면비교무명현차이(P>0.05)。결론고혈압합병관심병환자행신체파알연합안록지평치료구유량호적림상료효。
Objective:To analysis the clinical effects of Indapamide combined with Amlodipine in the treatment of hypertension combined with coronary heart disease (CHD). Methods:68 patients who were treated with hypertension combined with coronary heart disease in our hospital from May 2012 to July 2014 were chosen as the research object and were randomly divided into an experimental group (n=34) and a control group (n=34). The control group was treated with nifedipine controlled released tablets and the experimental group was implemented with indapamide and amlodipine therapy. Then the therapeutic effects and adverse reactions of the two groups were observed and analyzed. Results:The experimental results show that the overall ef昀cacy of treatment group patients is significantly higher than that of the control group (P<0.05). In terms of adverse reactions, the two groups had no signi昀cant difference (P>0.05). Conclusion:Indapamide combined with Amlodipine have excellent clinical effects in the treatment of hypertension combined with coronary heart disease.